As a result, more than one million active cases have been successfully treated, while the incidence of the disease – which has cost Indonesia’s economy millions of dollars in lost productivity – has been driven down. With technical support like this, Indonesia’s government is creating an affordable and sustainable national health-care system that will be fully financed with domestic resources by 2019.